Skip to main content

Life Science Venture Capital Financing and Fundraising Activity Remain Slow, Despite Surge in Biotech IPO Activity, According to First Half 2013 Fenwick & West Survey

By September 17, 2013News
fenwick-west-llp-logo

fenwick-west-llp-logo

Fenwick & West LLP, one of the nation’s premier law firms providing comprehensive legal services to high technology and life science clients, today announced the results of its First Half 2013 Life Science Venture Capital Survey.

The survey analyzes the valuations and terms of venture financings for 149 life science companies headquartered in the United States that reported raising capital during the first half of 2013, as well as trends in venture capital financings, fundraising and exit events.

{iframe}http://www.sacbee.com/2013/09/16/5741075/life-science-venture-capital-financing.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.